Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2018
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 16 Feb 2018 Status changed from active, no longer recruiting to completed.
- 24 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Nov 2017.